| RS2146497558 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146497910 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS2146498117 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS2146499114 |
TNRC6B
|
Health Risk |
Pathogenic |
— |
| RS2146499719 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS2146500403 |
TNRC6B
|
Health Risk |
Pathogenic |
Global developmental delay with speech and behavioral abnormalities, Global developmental delay with speech and behavioral abnormalities |
| RS2146500556 |
TNRC6B
|
Health Risk |
Pathogenic |
— |
| RS2146500943 |
TNRC6B
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2146501061 |
TNRC6B
|
Health Risk |
Pathogenic |
— |
| RS2146504324 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS2146505319 |
MIB1
|
Health Risk |
Likely pathogenic |
— |
| RS2146506059 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2146507793 |
ITCH
|
Health Risk |
Pathogenic |
Syndromic multisystem autoimmune disease due to ITCH deficiency, Syndromic multisystem autoimmune disease due to ITCH deficiency |
| RS2146508910 |
MIB1
|
Health Risk |
Likely pathogenic |
— |
| RS2146511357 |
MIB1
|
Health Risk |
Likely pathogenic |
— |
| RS2146511363 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS2146512032 |
TNRC6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Global developmental delay with speech and behavioral abnormalities, Global developmental delay with speech and behavioral abnormalities |
| RS2146513906 |
CYP24A1
|
Health Risk |
Pathogenic |
— |
| RS2146514141 |
CYP24A1
|
Health Risk |
Pathogenic |
— |
| RS2146516794 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146518792 |
TNRC6B
|
Health Risk |
Pathogenic |
Global developmental delay with speech and behavioral abnormalities, Global developmental delay with speech and behavioral abnormalities |
| RS2146525207 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2146526778 |
ADGRG2
|
Health Risk |
Pathogenic |
Obstructive azoospermia, Obstructive azoospermia |
| RS2146528200 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2146531776 |
ITGB2
|
Health Risk |
Likely pathogenic |
Leukocyte adhesion deficiency 3, Leukocyte adhesion deficiency 3 |
| RS2146534178 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome |
| RS2146538658 |
ITGB2
|
Health Risk |
Pathogenic |
Leukocyte adhesion deficiency 1, Leukocyte adhesion deficiency 1 |
| RS2146541525 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146541571 |
SMARCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS2146543069 |
SMARCA4
|
Health Risk |
Likely pathogenic |
SMARCA4-related BAFopathy, SMARCA4-related BAFopathy |
| RS2146543631 |
ATP6AP2
|
Health Risk |
Likely pathogenic |
Syndromic X-linked intellectual disability Hedera type, Syndromic X-linked intellectual disability Hedera type |
| RS2146544783 |
IQSEC2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS2146546594 |
HPS4
|
Health Risk |
Pathogenic |
— |
| RS2146547822 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2146548006 |
IQSEC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 1 |
| RS2146548468 |
IQSEC2
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 1 |
| RS2146548512 |
TNRC6B
|
Health Risk |
Pathogenic |
Global developmental delay with speech and behavioral abnormalities, Global developmental delay with speech and behavioral abnormalities |
| RS2146553083 |
HPS4
|
Health Risk |
Pathogenic |
— |
| RS2146555632 |
HPS4
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2146563694 |
CFAP298
|
Health Risk |
Pathogenic |
Heterotaxy, Heterotaxy |
| RS2146565741 |
TNRC6B
|
Health Risk |
Pathogenic |
Global developmental delay with speech and behavioral abnormalities, Global developmental delay with speech and behavioral abnormalities |
| RS2146568828 |
DSCAM
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2146569465 |
TNRC6B
|
Health Risk |
Pathogenic |
Global developmental delay with speech and behavioral abnormalities, Global developmental delay with speech and behavioral abnormalities |
| RS2146570387 |
TNRC6B
|
Health Risk |
Pathogenic |
— |
| RS2146578225 |
GDF5
|
Health Risk |
Conflicting classifications of pathogenicity |
GDF5-related disorder, 9 conditions |
| RS2146578516 |
GDF5
|
Health Risk |
Pathogenic |
— |
| RS2146579283 |
GDF5
|
Health Risk |
Pathogenic |
Brachydactyly type C, Brachydactyly type C |
| RS2146581345 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146582412 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146582432 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146582443 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146582657 |
SMC1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 85 |
| RS2146582701 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Developmental and epileptic encephalopathy |
| RS2146582931 |
GDF5
|
Health Risk |
Pathogenic |
Grebe syndrome, Grebe syndrome |
| RS2146583022 |
GDF5
|
Health Risk |
Pathogenic |
Brachydactyly type C, Brachydactyly type C |
| RS2146589489 |
TNFRSF13C
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS2146591222 |
COQ9
|
Health Risk |
Pathogenic |
— |
| RS2146592407 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146592415 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146593421 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146595244 |
CNOT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with speech delay, autism |
| RS2146595285 |
CNOT3
|
Health Risk |
Likely pathogenic |
— |
| RS2146595540 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146598241 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146598316 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146598341 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146599304 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Epileptic encephalopathy |
| RS2146599324 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146599339 |
SMC1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 85 |
| RS2146599361 |
SMC1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 85 |
| RS2146599371 |
SMC1A
|
Health Risk |
Pathogenic |
— |
| RS2146599539 |
SMC1A
|
Health Risk |
Pathogenic |
SMC1A-related cohesinopathy, SMC1A-related cohesinopathy |
| RS2146599562 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Developmental and epileptic encephalopathy |
| RS2146599602 |
SMC1A
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2146599709 |
SMC1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146599714 |
SMC1A
|
Health Risk |
Likely pathogenic |
— |
| RS2146599723 |
SMC1A
|
Health Risk |
Likely pathogenic |
— |
| RS2146599783 |
SMC1A
|
Health Risk |
Pathogenic |
— |
| RS2146599836 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146600016 |
SMC1A
|
Health Risk |
Pathogenic |
— |
| RS2146600076 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146600868 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS2146603666 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS2146604602 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146604722 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146604738 |
SMC1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 85 |
| RS2146605339 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146605369 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146605443 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146605568 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, SMC1A-related disorder |
| RS2146605644 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146606502 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146606566 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146606642 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146607840 |
ALG12
|
Health Risk |
Pathogenic |
ALG12-congenital disorder of glycosylation, ALG12-congenital disorder of glycosylation |
| RS2146614137 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS2146616137 |
TLK2
|
Health Risk |
Pathogenic |
— |
| RS2146616671 |
TLK2
|
Health Risk |
Likely pathogenic |
— |
| RS2146617330 |
TLK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 57 |
| RS2146620645 |
TMEM94
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with cardiac defects and dysmorphic facies, Intellectual developmental disorder with cardiac defects and dysmorphic facies |